Stock Analiz

Johnson & Johnson (JNJ) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026

Summary

Johnson & Johnson’s revenue went from $71.9B in fiscal 2016 to $94.2B in fiscal 2025, growth of about 3.0% a year.

Net income in fiscal 2025 was $26.8B, a net margin of 28.5%; the best year in this period was 2023 with $35.2B.

Over the twelve months to September 27, 2026, revenue was $99.3B and net income $16.1B.

Free cash flow was $19.7B in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count fell 13% over the period (buybacks).

Revenue, profit and cash flow by year

Revenue
2016: $71.9B162017: $76.5B172018: $81.6B182019: $82.1B192020: $82.6B202021: $78.7B212022: $80.0B222023: $85.2B232024: $88.8B242025: $94.2B25$94.2B
Net income
2016: $16.5B162017: $1.3B172018: $15.3B182019: $15.1B192020: $14.7B202021: $20.9B212022: $17.9B222023: $35.2B232024: $14.1B242025: $26.8B25$26.8B
Free cash flow
2016: $15.5B162017: $17.8B172018: $18.5B182019: $19.9B192020: $20.2B202021: $19.8B212022: $17.2B222023: $18.2B232024: $19.8B242025: $19.7B25$19.7B
EPS (diluted)
2016: $5.93162017: $0.47172018: $5.61182019: $5.63192020: $5.51202021: $7.81212022: $6.73222023: $13.72232024: $5.79242025: $11.0325$11.03

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$99.3B$94.2B$88.8B$85.2B$80.0B$78.7B$82.6B$82.1B$81.6B$76.5B$71.9B
Gross profit$67.1B$63.9B$61.4B$58.6B$55.4B$55.3B$54.2B$54.5B$54.5B$51.0B$50.1B
Operating income$18.7B$33.6B$17.4B$15.8B$19.6B$19.4B$16.7B$17.6B$19.0B$18.6B$20.5B
Net income$16.1B$26.8B$14.1B$35.2B$17.9B$20.9B$14.7B$15.1B$15.3B$1.3B$16.5B
EPS (diluted)$6.59$11.03$5.79$13.72$6.73$7.81$5.51$5.63$5.61$0.47$5.93
R&D$16.1B$109M$1.8B$483M$0$0$12.2B$11.4B$10.8B$10.6B$9.1B
Revenue growth—+6.0%+4.3%+6.5%+1.6%−4.7%+0.6%+0.6%+6.7%+6.3%+2.6%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$26.2B$24.5B$24.3B$22.8B$21.2B$23.4B$23.5B$23.4B$22.2B$21.1B$18.8B
Capital spending-$5.6B-$4.8B-$4.4B-$4.5B-$4.0B-$3.7B-$3.3B-$3.5B-$3.7B-$3.3B-$3.2B
Free cash flow$20.6B$19.7B$19.8B$18.2B$17.2B$19.8B$20.2B$19.9B$18.5B$17.8B$15.5B
Dividends paid$12.7B$12.4B$11.8B$11.8B$11.7B$11.0B$10.5B$9.9B$9.5B$8.9B$8.6B
Buybacks$7.9B$6.0B$2.4B$5.1B$6.0B$3.5B$3.2B$6.7B$5.9B$6.4B$9.0B
Stock-based pay$1.4B$1.4B$1.2B$1.2B$1.1B$1.1B$1.0B$977M$978M$962M$878M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$20.1B$24.5B$22.9B$22.3B$31.6B$25.2B$19.3B$19.7B$18.3B$41.9B
Debt—$42.8B$33.6B$28.4B$29.7B$33.1B$35.5B$28.7B$30.3B$32.2B$24.1B
Equity—$81.5B$71.5B$68.8B$76.8B$74.0B$63.3B$59.5B$59.8B$60.2B$70.4B
Total assets—$199.2B$180.1B$167.6B$187.4B$182.0B$174.9B$157.7B$153.0B$157.3B$141.2B
Shares (diluted)2.45B2.43B2.43B2.56B2.66B2.67B2.67B2.68B2.73B2.75B2.79B

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin67.6%67.9%69.1%68.8%69.2%70.3%65.6%66.4%66.8%66.7%69.7%
Operating margin18.8%35.6%19.6%18.6%24.6%24.6%20.2%21.5%23.3%24.3%28.6%
Net margin16.2%28.5%15.8%41.3%22.4%26.5%17.8%18.4%18.8%1.7%23.0%
FCF margin20.7%20.9%22.3%21.4%21.5%25.1%24.4%24.3%22.7%23.2%21.6%
ROIC—22.2%14.0%14.4%15.6%16.8%15.1%17.5%17.9%15.9%18.1%
ROE—32.9%19.7%51.1%23.4%28.2%23.2%25.4%25.6%2.2%23.5%

Frequently asked questions

What is Johnson & Johnson’s annual revenue?

$94.2B in fiscal 2025 and $99.3B over the twelve months to September 27, 2026.

How much profit does Johnson & Johnson make?

Net income was $26.8B in fiscal 2025 (net margin 28.5%).

Is Johnson & Johnson’s revenue growing?

Yes: revenue rose 6.0% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.